Mankind Pharma Ltd is a 34-year-old pharma company led by Mr Ramesh Juneja (Chairman & Whole-Time Director), Mr Rajeev Juneja (Vice Chairman & MD), and Mr Sheetal Arora (CEO & Whole-Time Director), and they have a more than 21,000-strong workforce. They are present in 25 countries. Their products are Pharmaceuticals, Generic drugs, OTC, FMCG, Diagnostics, etc. Mankind has shown nearly 100% growth in its share price in the last 5 years. However, their revenue is 12,207 crore and their net profit is 2,007 crore for FY 2024-25.

Establishment:

New Delhi in 1991 by Mr. Ramesh C. Juneja and Rajeev Juneja

Website:

Company Listed On:

National Stock Exchange (NSE) and Bombay Stock Exchange (BSE)

Core Business:

Pharmaceuticals, Generic Drugs, OTC Products, FMCG, Diagnostics

Financial Performance:

Revenue of ₹12,207 crore and net profit of ₹2,007 crore for FY 2024–25
Strong share price growth of nearly 100% over the last 5 years

Future Outlook:

• Global Expansion
• Involvements into FMCG and diagnostics segments
• Involvements into affordable healthcare and generic medicines

Focused on innovation and brand building